The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
International Consensus Study of Antipsychotic Dosing
Abstract
OBJECTIVE: Potency equivalents for anti-psychotic drugs are required to guide clinical dosing and for designing and interpreting research studies. Available dosing guidelines are limited by the methods and data from which they were generated. METHOD: With a two-step Delphi method, the authors surveyed a diverse group of international clinical and research experts, seeking consensus regarding antipsychotic dosing. The authors determined median clinical dosing equivalents and recommended starting, target range, and maximum doses for 61 drugs, adjusted for selected clinical circumstances. RESULTS: Participants (N=43) from 18 countries provided dosing recommendations regarding treatment of psychotic disorders for 37 oral agents and 14 short-acting and 10 long-acting parenteral agents. With olanzapine 20 mg/day as reference, estimated clinical equivalency ratios of oral agents ranged from 0.025 for sulpiride to 10.0 for trifluperidol. Seventeen patient and treatment characteristics, including age, hepatic and renal function, illness stage and severity, sex, and diagnosis, were associated with dosing modifications. CONCLUSIONS: In the absence of adequate prospective, randomized drug-drug comparisons, the present findings provide broad, international, expert consensus-based recommendations for most clinically employed antipsychotic drugs. They can support clinical practice, trial design, and interpretation of comparative antipsychotic trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research guidelines for the Delphi survey technique
Hasson, F. (2000) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2000.01567.x · Cited by 5,951
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Jones, P. B., Barnes, T. R. E., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,105
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini, R. J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250095013 · Cited by 545
Self-citationLeucht, S., Komossa, K., Rummel-Kluge, C., Corves, C., Hunger, H., Schmid, F., Asenjo Lobos, C., Schwarz, S., & Davis, J. M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030368 · Cited by 490
Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002136 · Cited by 489
Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
Modern antipsychotic drugs: a critical overview
Gardner, D. M. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041064 · Cited by 422
Self-citationComparative Doses and Costs of Antipsychotic Medication
Davis, J. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770070088010 · Cited by 407
Dose Response and Dose Equivalence of Antipsychotics
Davis, J. M., & Chen, N. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000117422.05703.ae · Cited by 358
Mauri, M. C., Volonteri, L. S., Colasanti, A., Fiorentini, A., De Gaspari, I. F., & Bareggi, S. R. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746050-00001 · Cited by 246
Tauscher, J., Hussain, T., Agid, O., Verhoeff, N. P. L. G., Wilson, A. A., Houle, S., Remington, G., Zipursky, R. B., & Kapur, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1620 · Cited by 159
CATIE and CUtLASS: can we handle the truth?
Lewis, S. W., & Lieberman, J. A. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037218 · Cited by 149
Langlands, R. L., Jorm, A. F., Kelly, C., & Kitchener, B. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm099 · Cited by 131
Chlorpromazine Equivalents Versus Defined Daily Doses: How to Compare Antipsychotic Drug Doses?
Rijcken, C. A. W., Monster, T. B. M., Brouwers, J. R. B. J., & den Berg, L. T. W. D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000096247.29231.3a · Cited by 121
Who Are the New Users of Antipsychotic Medications?
Domino, M. E., & Swartz, M. S. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.5.507 · Cited by 120
Lin, K. M., Poland, R. E., Nuccio, I., Matsuda, K., Hathuc, N., Su, T., & Fu, P. C. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1307 · Cited by 110
Special Section on Implications of CATIE: Who Are the New Users of Antipsychotic Medications?
Domino, M. E., & Swartz, M. S. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.5.507 · Cited by 105
Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy
Pani, L., Pira, L., & Marchese, G. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.02.005 · Cited by 94
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
Nosè, M., Tansella, M., Thornicroft, G., Schene, A. H., Becker, T. M., Veronese, A., Leese, M., Koeter, M. W. J., Angermeyer, M. C., & Barbui, C. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328303ac75 · Cited by 83
LESLIE, D. L., & Rosenheck, R. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1534 · Cited by 75
Sim, K., Su, H. C., Fujii, S., Yang, S., Chong, M., Ungvari, G., Si, T., He, Y. L., Chung, E. K., Chan, Y. H., et al. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03304.x · Cited by 58
Parks, J., Radke, A., Parker, G. B., Foti, M. E., Eilers, R., Diamond, M., Svendsen, D. P., & Tandon, R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn019 · Cited by 43
Hospital use of antipsychotic drugs: polytherapy
Centorrino, F., Cincotta, S. L., Talamo, A., Fogarty, K. V., Guzzetta, F., Saadeh, M., Salvatore, P., & Baldessarini, R. J. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.08.002 · Cited by 38
Self-citationAntipsychotic Dosage at Hospital Discharge and Outcomes Among Persons With Schizophrenia
Sohler, N., Walkup, J. T., McAlpine, D. D., Boyer, C. A., & Olfson, M. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.9.1258 · Cited by 33
Clinical Practice Variations in Prescribing Antipsychotics for Patients With Schizophrenia
Owen, R. R., Fischer, E. P., Kirchner, J. E., Thrush, C. R., Williams, D. K., Cuffel, B. J., Elliott, C. E., & Booth, B. M. (2003) · American Journal of Medical Quality · doi:10.1177/106286060301800402 · Cited by 27
Ito, H., Arakawa, R., Takahashi, H., Takano, H., Okumura, M., Otsuka, T., Ikoma, Y., Shidahara, M., & Suhara, T. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009577 · Cited by 25
Goudie, A. J., & Cole, J. C. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107082904 · Cited by 18
Cited by
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561
Huhn, M., Nikolakopoulou, A., Schneider-Thoma, J., Krause, M., Samara, M., Peter, N., Arndt, T., Bäckers, L., Rothe, P., Cipriani, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31135-3 · Cited by 1,753
Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050503 · Cited by 1,132
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931
Using the Delphi expert consensus method in mental health research
Jorm, A. F. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415600891 · Cited by 765
Metadata
- Authors
- Gardner, D. M., Murphy, A. L., O'Donnell, H., Centorrino, F., & Baldessarini, R. J.
- Venue
- American Journal of Psychiatry
- Published
- 2010-06-01
- Volume
- 167
- Issue
- 6
- Pages
- 686-693
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2165988750
- Cited by
- 1,301
- References
- 30
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.